Manufacturer's investigation conclusion: a specific cause for the reported events (covid-19, respiratory failure, stroke and death), as well as a direct correlation to the heartmate 3 lvas, serial number: (b)(6), could not conclusively be determined through this evaluation.Per additional information from the clinical specialist, the device will not be returned for evaluation.The patient expired on (b)(6) 2021.No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The lvas kit was shipped on 09mar2016.The heartmate 3 lvas instructions for use is currently available.Section 1 of this document lists stroke, respiratory failure and death as adverse events that may be associated with the use of heartmate 3 left ventricular assist system.Section 6 of the ifu, ¿patient care and management¿ (under ¿anticoagulation¿), provides information regarding the recommended anticoagulation regimen, including inr values, as well as suggested anticoagulation modifications in the event that there is a risk of bleeding.No further information was provided.The manufacturer is closing the file on this event.
|